The primary objective of the KG Jebsen Coeliac Disease Research Centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective of the centre is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
Antibody-secreting plasma cells persist for decades in human intestine
Mar. 20, 2017 2:55 PM
Landsverk OJ, Snir O, Casado RB, Richter L, Mold JE, Réu P, Horneland R, Paulsen V, Yaqub S, Aandahl EM, Øyen OM, Thorarensen HS, Salehpour M, Possnert G, Frisén J, Sollid LM, Baekkevold ES, Jahnsen FL.
J Exp Med. 2017 Feb;214(2):309-317. doi: 10.1084/jem.20161590. PubMed PMID: 28104812